Telithromycin cost?

Why was Telithromycin pulled from the U.S. market?
Telithromycin (brand name Ketek) was removed from the U.S. drug supply in 2011 after reports linked it to serious liver injury and other adverse events. The FDA required the withdrawal to protect patient safety, so the drug is no longer sold by U.S. manufacturers or pharmacies.

What’s the current availability of Telithromycin outside the U.S.?
The antibiotic is still marketed in a handful of countries, mainly in parts of Europe and Asia. Because it is no longer produced in the U.S., pricing data from American sources are scarce. In the markets where it remains sold, the drug is typically offered in 0.5 mg/mL solution or oral suspension, with a standard 10‑day course.

How much does a Telithromycin course cost abroad?
Prices vary widely. In Germany, for example, a 10‑day supply may be billed at roughly €120–€150 per patient (about $120–$140). In India, a generic version can be found for roughly ₹1,200–₹1,500 (about $15–$20). These figures reflect the average wholesale price; the actual amount patients pay depends on local pharmacy pricing, insurance coverage, and dispensing fees.

Can I still get Telithromycin in the U.S. through importation?
Some patients obtain the drug via overseas pharmacies or direct‑to‑consumer imports. However, the U.S. Food and Drug Administration does not approve these imports, and they may lack the necessary safety labeling or quality controls. Importing medication also carries legal and logistical risks, so it is generally not recommended unless a licensed prescriber provides explicit guidance.

Are there cheaper alternatives for treating the conditions Telithromycin targets?
Yes. For community‑acquired pneumonia or acute bacterial exacerbation of chronic bronchitis, clinicians typically prescribe macrolides such as azithromycin or clarithromycin, or newer agents like doxycycline or levofloxacin. These drugs are widely available in the U.S. and often have lower costs—typically $30–$70 for a 10‑day course—while maintaining comparable efficacy for many patients.

What should a patient consider if they’re looking for an affordable treatment?
Patients should discuss the latest evidence, safety profile, and cost with their prescriber. Generic options are usually preferred for cost savings and proven efficacy. If a clinician still recommends a ketolide, they may consider a local generic brand that meets FDA or international safety standards.